Mekanocross focuses on mechanochemical conversion of solution-phase organic synthesis reactions and the development of insoluble high-performance materials. The company provides mechanochemical organic-synthesis process technology and works with domestic and international pharmaceutical and chemical manufacturers to introduce those processes. It aims to support adoption of mechanochemical organic-synthesis processes across industry partners. Mekanocross is headquartered in Sapporo, Hokkaido and was founded in November 2023. Its stated paid-in capital is ¥3 million. In September 2025 the company completed a pre-Series A financing that brought cumulative funding to approximately ¥1 billion. Mechanocross commercializes a mechanochemical organic synthesis process that drives reactions via mechanical stirring, allowing reactions with extremely small or no solvents. The technology claims higher productivity, much lower CO2 emissions versus conventional solvent‑based processes, and compact, lower‑capex equipment. It also enables synthesis of previously insoluble or hard‑to‑make functional materials used in pharmaceuticals, semiconductors, displays, battery materials and other high‑performance applications. The company is working with pharmaceutical and chemical manufacturers on process introduction proofs and aims for full market entry after 2026. Mechanocross intends to establish domestic mass‑production technology (currently demonstrated up to several kilograms) and accelerate commercial expansion into Europe. Financially, the company completed a ¥200M seed raise to support scale‑up and international expansion; the company was founded in November 2023 and is headquartered in Sapporo, Hokkaido, with research ties to Hokkaido University.

Total raised

$8M

Funding rounds

2

Latest round

Series A

Latest activity

Sep 2025